Jupiter Life Line Hospitals Ltd

JLHL

Watchlist

AI Mode

‌

Market Cap

₹ 9,260 Cr

P/E

46.66

‌

Investment Checklist

How to read checklist?

Performance

STEADY PERFORMER

Valuation

REASONABLE

Growth

STABLE

Profitability

MODERATE MARGIN

Technicals

Bearish

Risk

LOW RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Jupiter Life Line Hospitals Limited is a leading multi-speciality healthcare provider in Western India with operations in Mumbai metropolitan area, Thane, Pune, and Indore.

In recent developments, the company has reported robust growth with a revenue increase of 14.9% year-on-year for H1 FY26, highlighting strong financial performance and expansion strategy.

The ongoing construction of the Dombivali hospital is a major strategic step, expected to enhance service capacity with potential 500-bed facility, underscoring their commitment to capacity expansion.

The IPO in 2023 marked a significant milestone, raising Rs 869 Crore, which aids in financing new projects and further strengthens their financial foundation.

The company's emphasis on advanced healthcare technology, including robotic surgeries and treatments, positions it as a forward-thinking and innovative player in the healthcare sector.

Sector

Healthcare

Industry

Hospitals / Medical Services

Market Cap

9,260 Cr

Volatility

Low Risk

P/E Ratio

46.7

Industry P/E

62.6

PEG Ratio

2.9

P/B Ratio

6.4

52W High

1,759.00

52W Low

1,250.00

Sales CAGR

17.52%

17.27%

18.02%

10Y

—

Profit CAGR

9.56%

29.69%

44.19%

10Y

—

ROE

TTM

13.68%

14.17%

14.67%

10Y

—

ROCE

TTM

15.59%

18.21%

17.49%

10Y

—

Technicals

‌

Forecasts

No. of Analysts

11

1Y Price Target

1847.22 ▲ 30.90%

Q3 EPS Estimate

Q3 Revenue Estimate

Unlock Premium Features

Price, EPS and Revenue Projections

Strong SellSellHoldBuyStrong Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

updated on

Dec 03, 2025

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
RAINBOW	1364.90	13,821 Cr	54.46	9.10	0.22	16.72	17.60	9.86
HCG	720.25	10,157 Cr	286.97	11.03	0.00	3.84	7.73	1.15
JLHL	1413.00	9,260 Cr	46.66	6.38	0.07	13.68	15.59	9.83
YATHARTH	698.45	6,717 Cr	44.04	3.98	0.00	9.03	11.86	8.22
KOVAI	6025.00	6,571 Cr	28.75	5.52	0.17	19.21	21.31	11.92
INDRAMEDCO	488.45	4,478 Cr	25.63	6.80	0.92	26.54	34.84	18.31
ARTEMISMED	280.95	4,453 Cr	46.91	3.89	0.14	10.76	13.34	6.64

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	243	263	273	290	287	323	321	327	348	394
Expenses	190	202	211	228	223	248	246	248	270	301
Operating Profit	53	61	62	62	64	75	75	78	78	92
OPM %	21.79	23.19	22.69	21.44	22.24	23.25	23.39	23.95	22.47	23.44
Other Income	3.65	3.20	7.91	11	8.37	9.44	8.30	7.03	13	11
Interest	12	12	1.03	0.93	1.08	1.12	2.78	5.57	8.26	7.84
Depreciation	11	11	11	10	11	14	14	18	21	21
Profit Before Tax	34	41	58	62	60	69	67	62	62	74
Tax %	-59.95	18.59	24.83	27.22	25.84	25.25	21.09	27.73	28.70	22.57
Net Profit	54	34	44	45	45	52	53	45	44	57
EPS in Rs	—	5.67	6.56	6.49	6.80	7.86	8.01	6.84	6.69	8.75

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	463	486	733	893	1,070	1,262	1,318
Expenses	380	419	580	691	831	965	1,011
Operating Profit	83	67	153	201	238	297	306
OPM %	17.84	13.81	20.92	22.56	22.27	23.51	23.25
Other Income	1.89	4.11	3.82	8.22	26	29	38
Interest	26	39	44	42	26	11	18
Depreciation	26	31	36	39	42	57	67
Profit Before Tax	33	1.56	77	129	195	258	259
Tax %	9.90	247.72	33.70	43.36	9.62	24.91	25.60
Net Profit	30	-2.30	51	73	177	194	193
EPS in Rs	—	—	—	12.94	28.65	29.51	30.29
Dividend Payout %	0.00	0.00	0.00	0.00	3.49	3.39	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	51	51	51	57	66	66
Reserves	186	188	243	309	1,103	1,291
Borrowings	272	426	495	469	0.00	393
Other Liabilities	94	124	120	151	112	156
Total Liabilities	603	789	909	986	1,281	1,905
Fixed Assets	435	630	684	720	718	977
CWIP	11	26	27	29	74	185
Investments	2.32	7.36	2.88	1.55	17	114
Other Assets	156	126	195	235	473	628
Total Assets	603	789	909	986	1,281	1,905

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	74	123	137	117	115	253
Cash from Investing Activity	-43	-295	-84	-104	-76	-209
Cash from Financing Activity	-32	184	32	18	128	301
Net Cash Flow	-0.92	12	85	31	167	345

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	40.91%	40.91%	40.91%	40.91%	40.91%	40.91%	40.91%	40.91%	40.91%
FIIs	4.62%	3.97%	4.17%	6.06%	8.84%	10.04%	10.03%	9.77%	9.06%
DIIs	16.14%	17.35%	17.58%	17.27%	16.87%	15.74%	15.63%	15.82%	16.95%
Public	38.32%	37.77%	37.34%	35.76%	33.37%	33.30%	33.42%	33.50%	33.08%
Total Shareholders	54,782	39,348	35,107	35,797	34,081	33,914	33,956	34,192	34,361

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Nov 13, 2025	Sbi mutual fund	Bulk	Buy	1,497.80	346.53 Cr	23,13,615	3.52
Nov 13, 2025	Sbi mutual fund	Bulk	Sell	1,497.80	346.53 Cr	23,13,613	3.52
Aug 29, 2024	Raghavan vadapatra sayee	Block	Sell	1,310.00	13.10 Cr	1,00,000	0.15
Aug 29, 2024	Brindha raghavan	Block	Sell	1,310.00	13.10 Cr	1,00,000	0.15
Aug 29, 2024	Think india opportunities mas...	Block	Buy	1,310.00	26.20 Cr	2,00,000	0.30
Jun 21, 2024	Tibrewala ramakant sushma	Bulk	Sell	1,200.03	50.04 Cr	4,17,000	0.63
Sep 18, 2023	Elixir wealth management priv...	Bulk	Buy	1,051.90	36.67 Cr	3,48,628	0.53
Sep 18, 2023	Elixir wealth management priv...	Bulk	Sell	1,049.40	36.30 Cr	3,45,878	0.52

Projection

Unlock Premium Features

Get In-depth insights on EPS and Revenue forecasts

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q2 FY26

Investor Presentation

Q1 FY26

Investor Presentation

Q4 FY25

Investor Presentation

Q3 FY25

Investor Presentation

Q2 FY25

Investor Presentation

Q1 FY25

Investor Presentation

Q4 FY24

Investor Presentation

Q3 FY24

Showing 1 - 8 of 10

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
RAINBOW	1364.90	13,821 Cr	54.46	9.10	0.22	16.72	17.60	9.86
HCG	720.25	10,157 Cr	286.97	11.03	0.00	3.84	7.73	1.15
JLHL	1413.00	9,260 Cr	46.66	6.38	0.07	13.68	15.59	9.83
YATHARTH	698.45	6,717 Cr	44.04	3.98	0.00	9.03	11.86	8.22
KOVAI	6025.00	6,571 Cr	28.75	5.52	0.17	19.21	21.31	11.92
INDRAMEDCO	488.45	4,478 Cr	25.63	6.80	0.92	26.54	34.84	18.31
ARTEMISMED	280.95	4,453 Cr	46.91	3.89	0.14	10.76	13.34	6.64

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Overview

Detailed Summary

Jupiter Life Line Hospitals Limited is a leading multi-speciality healthcare provider in Western India with operations in Mumbai metropolitan area, Thane, Pune, and Indore.

In recent developments, the company has reported robust growth with a revenue increase of 14.9% year-on-year for H1 FY26, highlighting strong financial performance and expansion strategy.

The IPO in 2023 marked a significant milestone, raising Rs 869 Crore, which aids in financing new projects and further strengthens their financial foundation.

The company's emphasis on advanced healthcare technology, including robotic surgeries and treatments, positions it as a forward-thinking and innovative player in the healthcare sector.

Sector

Healthcare

Industry

Hospitals / Medical Services

Market Cap

9,260 Cr

Volatility

Low Risk

P/E Ratio

46.7

Industry P/E

62.6

PEG Ratio

2.9

P/B Ratio

6.4

52W High

1,759.00

52W Low

1,250.00

Sales CAGR

17.52%

17.27%

18.02%

10Y

—

Profit CAGR

9.56%

29.69%

44.19%

10Y

—

ROE

TTM

13.68%

14.17%

14.67%

10Y

—

ROCE

TTM

15.59%

18.21%

17.49%

10Y

—